- Summary
- Price Reports
- Price History
- Add To Your Stocklist
- View your Stocklist
- Basic Chart
- Interactive Chart
- Headlines
- Company Snapshot
- Summary Reports
- Free Annual Report
- Estimate Snapshot
- Estimate Report
- Mobile Quote
- Real-Time Quote
- Streaming Quote
|
Adamis Pharmaceuticals | Company Snapshot
-
![]()
-
-
-
Vol:
-
Last Trade:
|
ADAMIS PHARMACEUTICALS CORPORATION
Adamis Pharmaceuticals Corporation, formerly Cellegy Pharmaceuticals, Inc., is a specialty pharmaceutical company engaged engages in the research, development, and commercialization of prescription medicines for the treatment of viral infections. Adamis Pharmaceuticals is composed of two wholly owned subsidiaries, Adamis Labs and Adamis Viral Therapies. Adamis Labs is a commercial stage specialty pharmaceutical company targeting high-prescribing physicians in the allergy, respiratory and pediatric medicine market segments. To complement and add to the sales efforts of Adamis Labs, Adamis Viral Therapies is focused on the development of patented, highly-valued proprietary vaccine technology that Adamis believes has the potential to prevent or treat infections such as influenza or chronic hepatitis. Adamis also provides packaging for pharmaceutical and nutraceutical products. The company is headquartered in Del Mar, California.
|
|
| Symbol: |
ADMP |
| Exchange(s): |
OTCBB |
| Industry: |
Consumer Products (Biotechnology & Pharmaceuticals) |
| 5-Star Rating: |
 |
|
ANNUAL FINANCIALS
|
|
|
Dec 31, 2008
12 Months
us$
|
Dec 31, 2007
12 Months
us$
|
Dec 31, 2006
12 Months
us$
|
3Yr.
Growth
% Change
|
|
Total Revenue ($000)
|
0
|
0
|
2,660
|
-100.00
|
|
Earnings before Interest & Tax ($000)
|
-1,260
|
-1,730
|
10,140
|
N/A
|
|
Profit/Loss ($000)
|
-1,530
|
-1,920
|
9,340
|
N/A
|
|
Earnings per Share
|
-0.05
|
-0.64
|
3.08
|
N/A
|
|
Total Assets ($000)
|
160
|
2,090
|
4,140
|
-70.84
|
|
Dividends Per Share
|
0.00
|
0.00
|
0.00
|
|
|
Return on Com. Equity
|
-956.25
|
-90.35
|
-567.16
|
|
|
Employees
|
N/A
|
N/A
|
N/A
|
|
|
|
|
|
Trailing 12 Month Results
|
|
|
12 Months ended
Dec 31, 2009,us$
|
12 Months ended
Dec 31, 2008,us$
|
%Change
|
|
Total Revenue ($000)
|
N/A
|
N/A
|
N/A
|
|
Profit/Loss ($000)
|
N/A
|
N/A
|
N/A
|
|
Earnings per Share
|
N/A
|
N/A
|
N/A
|
|
Dividends Per Share
|
0.00
|
0.00
|
|
Number of Shares
|
45,970,000
|
3,000,000
|
|
|
|
|
|
COMPANY INFORMATION
|
| Key Personnel |
| CEO: Richard C. Williams, Chmn.; Interim C.E.O.; Dir. |
| CFO: Robert J. Caso, V.P. Fin.; C.F.O.; Sec. |
| |
| Contact Information |
| Address: |
2085B Quaker Point Drive,
Quakertown,
PA,
18951 |
Phone: |
215-529-6084 |
| Fax: |
650-616-2222 |
| Web Address: |
www.cellegy.com |
| E-Mail : |
robert.caso@cellegy.com |
| |
| Incorporation:
| United States |
| |
|
Securities:
|
ADMP-Q2
|
|
| |
|
|
| |
|
|
Financial data is provided by Zacks Investment Research.
| |
All information on this site is compiled by CTVglobemedia Publishing Inc. from reliable industry sources. While all efforts are made to ensure the accuracy of the information, CTVglobemedia Publishing Inc. and its related entities assume no liability for incorrect, incomplete, or missing information from this site. Past performance is not necessarily indicative of future performance. Prior to making any investment decision, consult with a qualified investment advisor.
Copyright © 2010 CTVglobemedia Publishing Inc. All rights reserved.
|
|
|
